Literature DB >> 18952128

The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation.

Lianyun Li1, Nia Soetandyo, Qiuyan Wang, Yihong Ye.   

Abstract

The zinc finger-containing protein A20 is a negative regulator of TNF-induced JNK (c-Jun-N-terminal kinase) and NFkappaB (nuclear factor kappaB) signaling. A20 is an unusual enzyme that contains both ubiquitinating and deubiquitinating activities. Although A20 is mostly localized in the cytosol, our recent studies reveal that a fraction of A20 can associate with a lysosome-interacting compartment in a manner that requires its carboxy terminal zinc fingers, but independent of its ubiquitin modifying activities. Whether the lysosome-associated A20 has a function in cellular signaling is unclear. Here, we demonstrate that A20 is capable of targeting an associated signaling molecule such as TRAF2 to the lysosomes for degradation. This process is dependent on the membrane tethering zinc finger domains of A20, but does not require A20 ubiquitin modifying activity. Our findings suggest a novel mode of A20 action that involves lysosomal targeting of signal molecules bound to A20.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952128      PMCID: PMC2657479          DOI: 10.1016/j.bbamcr.2008.09.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  40 in total

1.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol.

Authors:  Y Ye; H H Meyer; T A Rapoport
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

3.  TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.

Authors:  Xiaoming Li; Yili Yang; Jonathan D Ashwell
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

4.  Stress-induced decrease in TRAF2 stability is mediated by Siah2.

Authors:  Hasem Habelhah; Ian J Frew; Aaron Laine; Peter W Janes; Frederic Relaix; David Sassoon; David D L Bowtell; Ze'ev Ronai
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

5.  TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.

Authors:  H Hsu; J Huang; H B Shu; V Baichwal; D V Goeddel
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

6.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

Authors:  E G Lee; D L Boone; S Chai; S L Libby; M Chien; J P Lodolce; A Ma
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

Review 7.  A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis.

Authors:  R Beyaert; K Heyninck; S Van Huffel
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

Review 8.  TNF-R1 signaling: a beautiful pathway.

Authors:  Guoqing Chen; David V Goeddel
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

9.  Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein-protein interactions.

Authors:  M Klinkenberg; S Van Huffel; K Heyninck; R Beyaert
Journal:  FEBS Lett       Date:  2001-06-01       Impact factor: 4.124

10.  Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3.

Authors:  Qiuyan Wang; Lianyun Li; Yihong Ye
Journal:  J Cell Biol       Date:  2006-09-25       Impact factor: 10.539

View more
  38 in total

1.  A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.

Authors:  Karine Enesa; Herwig P Moll; Le Luong; Christiane Ferran; Paul C Evans
Journal:  FASEB J       Date:  2015-02-09       Impact factor: 5.191

2.  Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.

Authors:  Rebecca Feltham; Maryline Moulin; James E Vince; Peter D Mace; Wendy Wei-Lynn Wong; Holly Anderton; Catherine L Day; David L Vaux; John Silke
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

3.  A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.

Authors:  Kelly Verhelst; Isabelle Carpentier; Marja Kreike; Laura Meloni; Lynn Verstrepen; Tobias Kensche; Ivan Dikic; Rudi Beyaert
Journal:  EMBO J       Date:  2012-08-28       Impact factor: 11.598

4.  A20: attractive without showing cleavage.

Authors:  Kelly Verhelst; Geert van Loo; Rudi Beyaert
Journal:  EMBO Rep       Date:  2014-05-30       Impact factor: 8.807

Review 5.  A20: from ubiquitin editing to tumour suppression.

Authors:  Sarah G Hymowitz; Ingrid E Wertz
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

Review 6.  Regulation of NF-κB by deubiquitinases.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 7.  A20: linking a complex regulator of ubiquitylation to immunity and human disease.

Authors:  Averil Ma; Barbara A Malynn
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

Review 8.  Regulation of NF-κB signaling by the A20 deubiquitinase.

Authors:  Noula Shembade; Edward W Harhaj
Journal:  Cell Mol Immunol       Date:  2012-02-20       Impact factor: 11.530

9.  Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level.

Authors:  Xiao-Jun Wang; Donna D Zhang
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

10.  A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq.

Authors:  Angela C Boroughs; Rebecca C Larson; Nemanja D Marjanovic; Kirk Gosik; Ana P Castano; Caroline B M Porter; Selena J Lorrey; Orr Ashenberg; Livnat Jerby; Matan Hofree; Gabriela Smith-Rosario; Robert Morris; Joshua Gould; Lauren S Riley; Trisha R Berger; Samantha J Riesenfeld; Orit Rozenblatt-Rosen; Bryan D Choi; Aviv Regev; Marcela V Maus
Journal:  Mol Ther       Date:  2020-07-25       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.